RecallRadar

FDA Drug recall D-0798-2021

Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-323…

On 2021-09-22 the FDA classified a Class III recall of Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-323… by Viatris, citing failed Impurities/Degradation Specifications; out of specification for Related Compound.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0798-2021
ClassificationClass III
Statusterminated
Initiated2021-09-13
Published2021-09-22
Last updated2026-09-13 11:52 UTC
CompanyViatris
DistributionUS

Product

Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-3231-93

Reason

Failed Impurities/Degradation Specifications; out of specification for Related Compound

Identifiers

ndc0378-3224-93
ndc0378-3224-77
ndc0378-3225-93
ndc0378-3225-77
ndc0378-3231-93
ndc0378-3231-77
ndc0378-3232-93
ndc0378-3232-77
code_infoLot # 3107334, exp. date October 2021

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0798-2021%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.